Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines

Dermatologic Surgery

Volumn 33, Issue 11, 2007, Pages 1328-1333

  Lizarralde, Mónica ^a   Gutiérrez, Sara Helena ^a   Venegas, Adriana ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EYELID; FACIAL NERVE; FEMALE; FOLLOW UP; FREEZING; HUMAN; MALE; NERVE CONDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; DILUTION; DRUG POTENCY; DRUG STABILITY; NOTE;

ADULT; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG STORAGE; FACE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; REFRIGERATION; SKIN AGING;

EID: 35449004535     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33284.x     Document Type: Article

References (22)

1. Malhotra PS, Danahey DG, Hilger P. BOTOX injections for hyperfunctional facial lines [monograph on the Internet]. Atlanta (GA): WebMD, Inc.; last updated 2006 Nov 14. Available from :
2. Matarasso SL. Update on the aesthetic uses of botulinum A neurotoxin in facial rejuvenation. Curr Probl Dermatol 2001 13 : 46 52.
3. Mercandetti M, Cohen A, Chang EP. Facial analysis for skin resurfacing [monograph on the Internet]. Atlanta (GA) : WebMD, Inc. last updated 2005 Oct 20. Available from :.
4. Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996 34 : 788 97.
5. Neville JA, Salam T, Letsinger JA, et al. Increase in procedures performed at dermatology office visits from1995 to 2001. Dermatol Surg 2005 31 : 160 2.
6. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 1999 103 : 701 13.
7. Arnon S, Schechter R, Inglesby T, et al. Botulinum toxin as a biological weapon. JAMA 2001 285 : 1059 70.
8. Lowe N. Botulinum toxin type A for facial rejuvenation. Dermatol Surg 1999 24 : 1216 8.
9. Coleman-Moriarty K. The art of botulinum type A administration for management of facial rhytids. [serial on the Internet]. 2002 Mar. Available from :
10. Carruthers A, Carruthers J, Samireh S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg 2005 31 : 414 22.
11. Lowe NJ, Ascher B, Heckmann M, et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg 2005 31 : 257 62.
12. Binder WJ, Blitzer A, Brin MF. The management of hyperfunctional lines of the face with botulinum toxin A. Dermatol Surg 1998 24 : 1198 205.
13. Blitzer A, Binder WJ. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. Facial Plastic Surg Clin North Am 2001 9 : 395 404.
14. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 1994 94 : 94 9.
15. Fulton JE. Botulinum toxin: the Newport Beach experience. Dermatol Surg 1998 24 : 1219 24.
16. BOTOX (botulinum toxin type A) purified neurotoxin complex [monograph on the Internet]. Package insert. Irvine (CA): Allergan Inc.; 2004 Oct. Available from :
17. Gartlan MG, Hoffman HT. Crystalline preparation of botulinum toxin type A (BTX): degradation in potency with storage. Otolaryngol Head Neck Surg 1993 108 : 135 40.
18. Garcia A, Fulton JE. Cosmetic denervation of the muscles of facial expression with botulinum toxin. Dermatol Surg 1996 22 : 39 43.
19. Sloop RR, Cole BA, Escutin RO. Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use. Neurology 1997 48 : 249 53.
20. Jabor MA, Kaushik R, Shayani P, et al. Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit. Plast Reconstr Surg 2003 111 : 2419 26.
21. Hexsel DM, De Almeida AT, Rutowitsch M, et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application. Dermatol Surg 2003 29 : 523 9.
22. Lowe NJ, Ascher B, Heckmann M, et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg 2005 31 : 257 62.